Research Compounds
Browse research compounds by category, search by name, and view details instantly.
Showing 4 compounds

Triple agonist peptide targeting GLP-1, GIP, and Glucagon receptors simultaneously. The most potent weight-loss peptide in clinical trials. 99% purity.

Triple agonist peptide targeting GLP-1, GIP, and Glucagon receptors. Double-dose vial for extended research protocols. 99% purity, USA made.

GLP-1 receptor agonist peptide with a 165-hour half-life. The most clinically validated weight-management peptide worldwide. 99% purity, USA synthesized.

D-retro-inverso peptide that disrupts the FOXO4-p53 interaction in senescent cells, triggering selective apoptosis. 99% purity, USA synthesized.